The Psychological Risks Associated With the Non-medical Switch From Biologics to Biosimilars
Authors:
Open Access
- 27 January 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 12
Abstract
The Psychological Risks Associated With the Non-medical Switch From Biologics to BiosimilarsKeywords
This publication has 17 references indexed in Scilit:
- Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilarsPharmacoepidemiology and Drug Safety, 2019
- The non-medical switching of prescription medicationsPostgraduate Medicine, 2019
- Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication StrategiesJournal of Crohn's and Colitis, 2018
- Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar AgentBioDrugs, 2018
- Interchangeability of Biosimilars: A European PerspectiveBioDrugs, 2017
- Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty PhysiciansAdvances in Therapy, 2016
- Patient attitudes and understanding about biosimilars: an international cross-sectional surveyPatient Preference and Adherence, 2016
- An overview on cognitive aspects implicated in medical decisionsEuropean Journal of Internal Medicine, 2011
- Scientific factors for assessing biosimilarity and drug interchangeability of follow-on biologicsBiosimilars, 2011
- Nonspecific Medication Side Effects and the Nocebo PhenomenonJAMA, 2002